Beta-blocker, aspirin and statin usage after myocardial infarction in patients with and without COPD. A nationwide analysis from 1995 to 2015 in Denmark
Daniel Rasmussen, Uffe Bodtger, Morten Lamberts, Peter Lange, Magnus Jensen
European Respiratory Journal 2018 52: OA1933; DOI: 10.1183/13993003.congress-2018.OA1933
Daniel Rasmussen
1Respiratory Research Unit Zealand, Department of Respiratory Medicine, Naestved Hospital, Naestved, Denmark
Uffe Bodtger
1Respiratory Research Unit Zealand, Department of Respiratory Medicine, Naestved Hospital, Naestved, Denmark
Morten Lamberts
2Heart Centre, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark
Peter Lange
3Department of Public Health, Section of Social Medicine, University of Copenhagen, Copenhagen, Denmark
Magnus Jensen
4Department of Cardiology, Herlev and Gentofte University Hospital, Hellerup, Denmark
Vol 52 Issue suppl 62
Table of Contents
Beta-blocker, aspirin and statin usage after myocardial infarction in patients with and without COPD. A nationwide analysis from 1995 to 2015 in Denmark
Daniel Rasmussen, Uffe Bodtger, Morten Lamberts, Peter Lange, Magnus Jensen
European Respiratory Journal Sep 2018, 52 (suppl 62) OA1933; DOI: 10.1183/13993003.congress-2018.OA1933
Beta-blocker, aspirin and statin usage after myocardial infarction in patients with and without COPD. A nationwide analysis from 1995 to 2015 in Denmark
Daniel Rasmussen, Uffe Bodtger, Morten Lamberts, Peter Lange, Magnus Jensen
European Respiratory Journal Sep 2018, 52 (suppl 62) OA1933; DOI: 10.1183/13993003.congress-2018.OA1933